Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor
Copyright 1999 American Medical Association.
All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: The article by Dr
Hughes and colleagues1 on advances in pharmacotherapy of
smoking provides a good overview of the existing research regarding
bupropion and over-the-counter nicotine replacement therapy (NRT) as an
aid to smoking cessation. The authors conclude that "concomitant
behavioral or supportive therapy increases quit rates and should be
encouraged but not required." Although we agree with the general
conclusions, we would like to make the argument that concomitant
therapy should be required, a common practice in many hospital-based
smoking cessation programs.
Antonuccio DO, Danton WG. Adding Behavioral Therapy to Medication for Smoking Cessation. JAMA. 1999;281(21):1983-1985. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-21-jbk0602